Man Group’s MacroGenics MGNX Stock Holding History

Man Group’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$139K	Buy	+48,012	New	+$102K	﹤0.01%	2334
2022 Q4	–	Sell	-20,200	Closed	-$70K	–	2119
2022 Q3	$70K	Buy	+20,200	New	+$77.3K	﹤0.01%	1875
2021 Q1	–	Sell	-80,619	Closed	-$1.84M	–	1943
2020 Q4	$1.84M	Buy	80,619 +13,877	+21%	+$319K	0.01%	1227
2020 Q3	$1.68M	Sell	66,742 -3,851	-5%	-$105K	0.01%	1244
2020 Q2	$1.97M	Sell	70,593 -120,169	-63%	-$2.09M	0.01%	1072
2020 Q1	$1.11M	Buy	190,762 +37,444	+24%	+$340K	0.01%	1085
2019 Q4	$1.67M	Buy	153,318 +11,000	+8%	+$109K	0.01%	1375
2019 Q3	$1.82M	Sell	142,318 -191,142	-57%	-$2.75M	0.01%	1280
2019 Q2	$5.66M	Buy	333,460 +70,874	+27%	+$1.22M	0.02%	897
2019 Q1	$4.72M	Buy	262,586 +73,000	+39%	+$1.26M	0.02%	953
2018 Q4	$2.41M	Buy	189,586 +123,464	+187%	+$2.07M	0.01%	1130
2018 Q3	$1.42M	Buy	66,122 +53,906	+441%	+$1.15M	0.01%	1532
2018 Q2	$253K	Buy	+12,216	New	+$275K	﹤0.01%	1956

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Man Group's MGNX Position: Q1 2026 in Review

Man Group opened a new position in MacroGenics (MGNX) in Q1 2026: 48,012 shares worth $139K. The stake represents ﹤0.01% of the portfolio and ranks #2334 among its holdings. This is a return to the name: Man Group previously reported a position in MGNX as recently as Q3 2022.

Man Group first reported a position in MGNX in Q2 2018 and has held it in 13 quarters since. The position peaked at $5.66M in Q2 2019. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Man Group held 48,012 shares of MacroGenics worth $139K as of Q1 2026.
MacroGenics was a new Man Group position in Q1 2026.
MacroGenics made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2334 holding.
Man Group first reported a position in MacroGenics in Q2 2018 and has held it in 13 quarters since.
Man Group's MacroGenics position peaked at $5.66M in Q2 2019.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.